# Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects

> **NCT03817684** · PHASE2 · COMPLETED · sponsor: **Tetra Discovery Partners** · enrollment: 255 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** BPN14770
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03817684
- **Lead sponsor:** Tetra Discovery Partners
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-30
- **Primary completion:** 2020-02-04
- **Final completion:** 2020-02-04
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03817684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03817684, "Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03817684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*